The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Type of stress, not duration, key to heart enlargement

DURHAM, N.C. -- When judging whether or not an enlarged heart is healthy or potentially at risk for heart disease, the nature of the physiological stress that produced the enlargement is more important than the duration of the stress, according to a new study led by Duke University Medical Center investigators.

This distinction has significant clinical implications, the researchers said. While enlargement of the heart can be a natural and beneficial response to exercise training, it can also be an early warning sign for such harmful conditions as heart failure.

These findings, based on a series of experiments in mice, could help settle a long-running controversy among cardiologists concerning heart enlargement, or cardiac hypertrophy, according to Duke cardiologist Howard Rockman, M.D., who led the team of Duke and University of North Carolina-Chapel Hill researchers.

The researchers published their findings on June, 1, 2006, in the Journal of Clinical Investigation. The study was supported by the National Institutes of Health.

"If you look at the hearts of athletes, they are larger than normal," Rockman said. "On the other hand, patients with high blood pressure also tend have larger-than-normal hearts. So why are some cardiac overloads, such as exercise, good for the heart, while others, such as high blood pressure, not?"

In athletes, the heart's pumping chambers enlarge to compensate for the body's increased demand for oxygen-rich blood. But in patients with heart failure, the heart walls themselves become thicker, heavier and less efficient in pumping blood.

"For more than a century there has been intense debate over why some stresses or overloads on the heart are beneficial and others lead to disease," Rockman continued. "The prevailing wisdom was that since exercise is an intermittent event and high blood pressure is a chronic condition, the duration of the cardiac stress was key. However, our studies appear to d
'"/>

Contact: Richard Merritt
Merri006@mc.duke.edu
919-684-4148
Duke University Medical Center
1-Jun-2006


Page: 1 2 3

Related medicine news :

1. New study shows Rescue Remedy is an effective all-natural stress, anxiety reliever
2. Improving communication with families of dying patients reduces stress, anxiety and depression
3. Wartime raises stress, blood pressure rates in military offspring
4. Helping children handle stress, emotions may help stuttering
5. Chronic stress, depression and cortisol levels are potential risk indicators for periodontal disease
6. A recipe for overeating: Studies outline dangers of mixing stress, deprivation and tempting foods
7. A broader look at cardiac CTA images often finds diseases/disorders beyond the heart
8. Drug for cluster headaches may cause heart problems
9. Reductive stress linked to heart disease
10. Novel candidate biomarker for heart failure also strongly predicts risk of death
11. Many heart attack patients still not getting emergency clot-busting treatment

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Type stress not duration key heart enlargement

(Date:11/23/2009)...action might ease the problem, researchers say , ... who bottle up their anger over unfair treatment a...h study indicates. , Men who consistently faile...a fellow worker or supervisor were more than twice...disease as those who vented their anger, claims a ...
(Date:11/23/2009).../PRNewswire-FirstCall/--InfoLogix,Inc.(Nasdaq: IFL...solutionsforthehealthcareandcommercialindustries,a...edServicesatSiemensHealthServices,hasjoinedInfoLog..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...icHealthcareServicesforInfoLogix,Mr.Waywillberespo...
(Date:11/23/2009)...PRNewswire-USNewswire/--TheAmericanSocietyofHemato...ng,education,andmediacompany,arelaunching"Exploret...dtosparkinterestinthefieldsofscienceandmedicine,in...itiesinhematology. ,, "Manyhematologistsmayreme...ficent,whichmadelearningaboutbloodreallyfun,"state...
(Date:11/23/2009)... patients and survivors treated with chemotherapy ...me chronic conditions, hindering patients, ability...University of Rochester Medical Center. , A stud...leep troubles at nearly three times the rate of th...nt in younger patients and those with lung and bre...
(Date:11/23/2009)...are professionals enjoy a pay raise for a job well... for health care performance may actually backfire...performance ratings for 25 medical groups across C...nch of a statewide pay-for-performance program in ...productivity. , Reporting in the December edi...
Breaking Medicine News(10 mins):Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3
(Date:11/23/2009)...,, EXTON,Pa.,Nov.23/PRNewswire/--BioTrendsRe...(TM): Feraheme report,thesecondinamulti-phasesyn...G,snewIVironproduct,Feraheme,throughthefirstsixmon...esquantitativeinformationfrom50uniqueNephrologists...sassesstrialanduseofFeraheme,obstaclestouse,reason...
(Date:11/23/2009)...,, WALTHAM,Mass.,Nov.23/PRNewswire/--Proteon...alstudyofitsleadproduct,PRT-201,inend-stagerenaldi...usgraft(AVG)creation.TheAVGstudyrepresentsProteon,...eviouslyannouncingtheinitiationofaPhase1/2studyofP...ousfistula(AVF)creationearlierthisyear.Proteonalso...
(Date:11/23/2009)...,, SOUTHSANFRANCISCO,Calif.,Nov.23/PRNewswir...uncedthatDr.TedW.LoveandDr.DavidC.U,Prichardhaveag...etionoftheproposedmergerbetweenAnesivaandArcionThe...ldervotescheduledtotakeplaceatthepreviouslyannounc...nDecember3,2009at9:00a.m.PSTat400OysterPoint,Suite...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Study examines dietary influences of liver disease 50559 1Study examines dietary influences of liver disease 50559 2Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 1Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 2Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 3TeamHealth Recognized by National Quality Agency 50555 1TeamHealth Recognized by National Quality Agency 50555 2TeamHealth Recognized by National Quality Agency 50555 3
Other News:
...DIEGO, April 20, 2007 A policy paper and principl...ity to comment on performance ratings that they be... American College of Physicians (ACP) at its annua...eloping a Fair Process Through Which Physicians Pa...
...AM, N.C. -- Medical professionals conducting clini...inancial conflicts of interest before they talk to...at is one of the main conclusions of a new survey ... and Johns Hopkins University. Their study found t...
... unique collaborative paper in PLoS Medicine, a fo...marketing reveal the tactics used by drug reps to ... reps increase drug sales by influencing physician...iendship," say the authors, Adriane Fugh-Berman (G...
...st half of sales visits by pharmaceutical company ...apentin led to doctors stating that they intended ...mmend it to colleagues, according to an analysis o...the visits.... Nearly 40 percent of the visits inv...
health news:Physicians should be able to review performance rates before release 2health news:Physicians should be able to review performance rates before release 3health news:Physicians should be able to review performance rates before release 4health news:Clinical trial coordinators need more financial conflict-of-interest training 2health news:Clinical trial coordinators need more financial conflict-of-interest training 3health news:Drug reps use friendship to influence doctors 2health news:Drug company sales visits influenced doctors, study finds 2health news:Drug company sales visits influenced doctors, study finds 3
...NJ, January 31, 2000) -- Bristol-Myers Squibb anno...cation (NDA) with the U.S. Food and Drug Administr...so known as ddI. The new capsules contain enteric...ential medicine in VIDEX from degrading until it h...
...calling for all children to be properly restrained...Centre Ltd. are looking at ways to increase flight...ren. They estimate that an average of 5.6 million ...year. *..Roger Hardy, Director of the Cranfield Im...
...;o phenomenon -- the warming of the equatorial Pac...- has been linked to outbreaks of dengue, malaria,...kins School of Public Health, A.B. Prisma, and the...und that the 1997-1998 El Niño season incre...
... Wiesel Among Signatories of The Charter of Paris ... ... ... ... ... Paris, 4 Feb., 2000 - Today m...patient advocacy, cancer research organizations an...itment to the global eradication of cancer by sign...
health news:Bristol-Meyers Squibb submits NDA for new formulation of once daily videx(R)(didanosine) 2health news:Bristol-Meyers Squibb submits NDA for new formulation of once daily videx(R)(didanosine) 3health news:Cranfield pushes for greater child flight safety 2health news:Cancer summit launches global commitment to improve cancer care, research and treatment 2